Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: “Second International Workshop on Human Endogenous Retroviruses and Disease”, Washington DC, March 13th and 14th 2017-Reference-Cited by-同舟云学术

Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: “Second International Workshop on Human Endogenous Retroviruses and Disease”, Washington DC, March 13th and 14th 2017

Published:2017-07 Issue: Volume:15 Page:18-23
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Kremer David,Glanzman Robert,Traboulsee Anthony,Nath Avindra,Groc Laurent,Horwitz Marc,Göttle Peter,Perron Hervé,Gold Julian,Hartung Hans-Peter,Küry Patrick

Funder

AFM

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference36 articles.

1. CMV induces HERV-K and HERV-W expression in kidney transplant recipients;Bergallo;J. Clin. Virol.,2015

2. Evidence of selection on the domesticated ERVWE1 env retroviral element involved in placentation;Bonnaud;Mol. Biol. Evol.,2004

3. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV;Brudek;J. Neuroimmunol.,2007

4. Age-dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase-elevating virus in motor neurons;Contag;J. Virol.,1989

5. GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study;Curtin;Clin. Ther.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Neuroimmunology of Multiple Sclerosis: Fictions and Facts;Frontiers in Neurology;2022-02-07

2. Endogenous retrovirus HERV-K6 and HERV-K11 polymorphisms’ analyses in head and neck squamous cell carcinoma patients;Meta Gene;2021-06

3. A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study;Multiple Sclerosis and Related Disorders;2018-08

4. Detection of HERV‑K6 and HERV‑K11 transpositions in the human genome;Biomedical Reports;2018-05-14